Brian Lapham is an accomplished executive in the pharmaceutical and biotechnology sectors, currently serving as Executive Director and US Bemarituzumab Brand Lead at Amgen since April 2024. Prior to this role, Lapham held various senior leadership positions at AstraZeneca from March 2020 to April 2024, including Senior Director for US Brand Strategy & Marketing in Immuno-Oncology for Lung and Global Commercial Lead for Gastrointestinal Tumors. Earlier experience includes roles at Bristol Myers Squibb, where Lapham was involved in worldwide oncology commercialization, and at Amgen, focusing on oncology marketing and strategic planning. Additional experience encompasses consulting roles at The Frankel Group and Leerink Swann, alongside positions in research at Moffitt Cancer Center and consulting at Trinity Partners. Brian Lapham holds an AB in Environmental Science and Public Policy from Harvard University and an MS in Medical Science with a focus on Pharmacology from the University of South Florida.
This person is not in the org chart
This person is not in any teams
This person is not in any offices